Quest Diagnostics wins New York approval for cancer MRD test
Go back to Quest Diagnostics wins New York approval for cancer MRD test| Quest Diagnostics (NYSE: DGX) | Delayed: 209.83 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $209.83 | 52 Week High | $86.85 | |||
| Open | $209.83 | 52 Week Low | $59.66 | |||
| Day High | $209.83 | P/E | 39.52 | |||
| Day Low | $209.83 | EPS | $5.31 | |||
| Volume | 85,101 | |||||
